In 2021 NVGCT would like to provide weekly updates about ATMPs in clinical development. Happy reading!
Gene therapy for a subtype of eye disease approved in the Netherlands
From 2021, patients suffering from RPE65-associated retinal disease will be able to be treated in three UMCs of the Netherlands.
https://www.radboudumc.nl/nieuws/2020/gentherapie-voor-zeldzame-oogziekte-vergoed
Scientists develop new gene therapy for eye disease | EurekAlert! Science News
Scientists from Trinity College Dublin have developed a new gene therapy approach that offers promise for one day treating an eye disease that leads to a progressive loss of vision and affects thousands of people across the globe. The study, which involved a collaboration with clinical teams in the Royal Victoria Eye and Ear Hospital and the Mater Hospital, also has implications for a much wider suite of neurological disorders associated with ageing.
Source: Scientists develop new gene therapy for eye disease | EurekAlert! Science News
In memoriam prof. Gertjan van Ommen
Condolences can be shared on: https://www.remembr.com/en/g.van.ommen
Condolences can also be sent to: mjkuip11@gmail.com or
mrs. R. Kuip, Apollolaan 36, 1511 DE Oostzaan, The Netherlands